Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells

被引:14
作者
Boxall, S. A. [1 ]
Cook, G. P. [1 ]
Pearce, D. [2 ]
Bonnet, D. [2 ]
El-Sherbiny, Y. M. [1 ]
Blundell, M. P. [3 ]
Howe, S. J. [3 ]
Leek, J. P. [1 ]
Markham, A. F. [1 ,2 ]
de Wynter, E. A. [1 ]
机构
[1] Univ Leeds, Dept Mol Gastroenterol, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England
[2] London Res Inst, Haematopoiet Stem Cell Lab, London, England
[3] UCL, Mol Immunol Unit, Inst Child Hlth, London, England
关键词
haematopoietic stem cells; cord blood; NOD/SCID mice; CD133; aldehyde dehydrogenase activity; ALDEHYDE DEHYDROGENASE-ACTIVITY; IMMUNE-DEFICIENT MICE; MARROW CD34(-) CELLS; VERSUS-HOST-DISEASE; STEM-CELLS; NOD/SCID MICE; IN-VIVO; MULTILINEAGE EXPRESSION; CAPACITY; TRANSPLANTATION;
D O I
10.1038/bmt.2008.368
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We have demonstrated previously that cord blood CD133(+) cells isolated in the G(0) phase of the cell cycle are highly enriched for haematopoietic stem cell (HSC) activity, in contrast to CD133(+) G(1) cells. Here, we have analysed the phenotype and functional properties of this population in more detail. Our data demonstrate that a large proportion of the CD133(+) G(0) cells are CD38 negative (60.4%) and have high aldehyde dehydrogenase activity (75.1%) when compared with their CD133(+) G(1) counterparts (13.5 and 4.1%, respectively). This suggests that stem cell activity resides in the CD133(+) G(0) population. In long-term BM cultures, the CD133(+) G(0) cells generate significantly more progenitors than the CD34(+) G(0) population (P < 0.001) throughout the culture period. Furthermore, a comparison of CD133(+) G(0) versus CD133(+) G(1) cells revealed that multilineage reconstitution was obtained only in non-obese diabetic/SCID animals receiving G 0 cells. We conclude that CD133(+) cells in the quiescent phase of the cell cycle have a phenotype consistent with HSCs and are highly enriched for repopulating activity when compared with their G(1) counterparts. This cell population should prove useful for selection and manipulation in ex vivo expansion protocols. Bone Marrow Transplantation (2009) 43, 627-635; doi: 10.1038/bmt.2008.368; published online 10 November 2008
引用
收藏
页码:627 / 635
页数:9
相关论文
共 35 条
[1]  
[Anonymous], ANN N Y ACAD SCI
[2]   A newly discovered class of human hematopoietic cells with SCID-repopulating activity [J].
Bhatia, M ;
Bonnet, D ;
Murdoch, B ;
Gan, OI ;
Dick, JE .
NATURE MEDICINE, 1998, 4 (09) :1038-1045
[3]   Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice [J].
Bhatia, M ;
Wang, JCY ;
Kapp, U ;
Bonnet, D ;
Dick, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5320-5325
[4]   AC133 expression in human stem cells [J].
Bhatia, M .
LEUKEMIA, 2001, 15 (11) :1685-1688
[5]   Umbilical cord blood transplantation and banking [J].
Brunstein, CG ;
Wagner, JE .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :403-417
[6]   Expression of novel surface antigens on early hematopoietic cells [J].
Bühring, HJ ;
Seiffert, M ;
Bock, TA ;
Scheding, S ;
Thiel, A ;
Scheffold, A ;
Kanz, L ;
Brugger, W .
HEMATOPOIETIC STEM CELLS: BIOLOGY AND TRANSPLANTATION, 1999, 872 :25-39
[7]   Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors [J].
Cashman, J ;
Dykstra, B ;
Clark-Lewis, I ;
Eaves, A ;
Eaves, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (09) :1141-1149
[8]   Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity [J].
Christ, Oliver ;
Lucke, Kai ;
Imren, Suzan ;
Leung, Karen ;
Hamilton, Melisa ;
Eaves, Allen ;
Smith, Clay ;
Eaves, Connie .
HAEMATOLOGICA, 2007, 92 (09) :1165-1172
[9]   Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution [J].
Dao, MA ;
Arevalo, J ;
Nolta, JA .
BLOOD, 2003, 101 (01) :112-118
[10]   Isolation and characterization of human CD34-Lin- and CD34+Lin- hematopoietic stem cells using cell surface markers AC133 and CD7 [J].
Gallacher, L ;
Murdoch, B ;
Wu, DM ;
Karanu, FN ;
Keeney, M ;
Bhatia, M .
BLOOD, 2000, 95 (09) :2813-2820